PRESS RELEASE published on 11/30/2024 at 02:35, 1 year 5 months ago GLG Life Tech Corporation Reports 2024 Third Quarter Financial Results GLG Life Tech Corporation announces financial results for the third quarter and nine months ended September 30, 2024, showing revenue increases and improved SG&A management. Details available on SEDAR and company website Financial Results GLG Life Tech Corporation Revenue Increases SG&A Management SEDDAR
BRIEF published on 08/30/2024 at 21:28, 1 year 8 months ago GLG Life Tech Corporation fait le point sur la radiation de la cote de la TSX et la cotation de la NEX FFCTO Bourse De Toronto Retrait De La Liste Déclarations Financières Cotation NEX
BRIEF published on 08/30/2024 at 21:28, 1 year 8 months ago GLG Life Tech Corporation Updates on TSX Delisting and NEX Listing TSX Delisting FFCTO Financial Filings NEX Listing
PRESS RELEASE published on 08/30/2024 at 21:23, 1 year 8 months ago GLG Life Tech Corporation Provides Update Regarding Delisting From TSX And Listing on NEX GLG Life Tech Corporation to transfer its listing to NEX exchange following TSX delisting review. Company seeks revocation of FFCTO for trading on NEX. Management focuses on reducing debt and increasing sales TSX GLG Life Tech Corporation FFCTO Delisting Review NEX Exchange
BRIEF published on 08/15/2024 at 01:15, 1 year 9 months ago GLG Life Tech Corporation publie des résultats financiers mitigés pour le deuxième trimestre 2024 Résultats Financiers Perte Nette Augmentation Des Revenus Retrait De La Liste Réduction Des Frais Généraux Et Administratifs
BRIEF published on 08/15/2024 at 01:15, 1 year 9 months ago GLG Life Tech Corporation Reports Mixed Second Quarter Financial Results for 2024 Financial Results Revenue Increase Delisting Net Loss SG&A Reduction
PRESS RELEASE published on 08/15/2024 at 01:10, 1 year 9 months ago GLG Life Tech Corporation Reports 2024 Second Quarter Financial Results GLG Life Tech Corporation reports significant revenue growth in Q2 2024. Company transfers Qingdao Runde Biotechnology facility, faces delisting review by TSX, and addresses cash flow concerns Revenue Growth Cash Flow Q2 2024 GLG Life Tech Corporation TSX Delisting Review
BRIEF published on 07/24/2024 at 02:20, 1 year 9 months ago GLG Life Tech Corporation publie ses résultats financiers du premier trimestre 2024 Résultats Financiers Réduction De La Dette Des Flux De Trésorerie Ventes De Stévia Examen De Radiation
BRIEF published on 07/24/2024 at 02:20, 1 year 9 months ago GLG Life Tech Corporation Reports 2024 First Quarter Financial Results Financial Results Cash Flow Debt Reduction Delisting Review Stevia Sales
PRESS RELEASE published on 07/24/2024 at 02:15, 1 year 9 months ago GLG Life Tech Corporation Reports 2024 First Quarter Financial Results GLG Life Tech Corporation reports $3.5 million revenue in Q1 2024, up 123% from Q1 2023, managing SG&A costs effectively. Financial results available on SEDAR and company website Financial Results Revenue GLG Life Tech Corporation SEDAR SG&A Costs
Published on 05/23/2026 at 03:15, 30 minutes ago UraniumX Approved for Trading on the OTCQB Venture Market and Announces Board Change
Published on 05/23/2026 at 03:00, 45 minutes ago Battery X Metals Reports Up to ~84 km Estimated Driving Range Increase Across Multiple BYD Electric Vehicles Following Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Trials, Demonstrating Performance Improvement Across the World’s Larges
Published on 05/23/2026 at 02:25, 1 hour 20 minutes ago Battery X Metals Announces up to $2 Million Private Placement Financing and Initiative to Strengthen Balance Sheet
Published on 05/23/2026 at 02:25, 1 hour 20 minutes ago Bolt Metals Completes 402 line-km MobileMT Survey at Northwind Property, Quebec
Published on 05/23/2026 at 01:00, 2 hours 45 minutes ago LIR Life Sciences Announces Initiation of Phase 1 Macromolecule-Enabled Transdermal Delivery Development with Neuland Laboratories
Published on 05/22/2026 at 22:05, 5 hours 40 minutes ago Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH
Published on 05/22/2026 at 22:05, 5 hours 40 minutes ago Abivax Presents Q1 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with UC
Published on 05/22/2026 at 19:51, 7 hours 54 minutes ago Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices
Published on 05/22/2026 at 18:33, 9 hours 12 minutes ago Update on Coupon payment due on 23 May 2026 and Preparation of the Green Bond Restructuring
Published on 05/22/2026 at 18:30, 9 hours 15 minutes ago Annual General Meeting of Curatis Holding AG approved all proposals of the Board of Directors
Published on 05/22/2026 at 19:35, 8 hours 10 minutes ago PROJET D'EVOLUTION DE SA GOUVERNANCE ET LA NOMINATION D'UN PRESIDENT DU DIRECTOIRE PAR INTERIM
Published on 05/22/2026 at 18:05, 9 hours 40 minutes ago Déclaration hebdomadaire d'opérations effectuées du 18 au 22 mai 2026
Published on 05/22/2026 at 18:05, 9 hours 40 minutes ago Disclosure of transactions in own shares from May 18 to May 22, 2026
Published on 05/22/2026 at 12:52, 14 hours 53 minutes ago Communiqué du Conseil d’administration – Assemblée Générale du 22 mai 2026
Published on 05/22/2026 at 12:52, 14 hours 53 minutes ago Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026